MarketScreener Editorial Features Neurokine Pharmaceuticals Inc Other OTC
Equities
CAC611561100
End-of-day quote
Other stock markets
|
||
- USD | - |
|
07-02 | BetterLife Pharma Inc. announced that it has received CAD 0.175 million in funding | CI |
06-27 | BetterLife Pharma Inc. Reports Earnings Results for the First Quarter Ended April 30, 2024 | CI |
- Stock Market
- Equities
- BETRF Stock
- Stock
- News Neurokine Pharmaceuticals Inc
- MarketScreener Editorial Features